Lít-va - Tiếng Lít-va - SMCA (Valstybinė vaistų kontrolės tarnyba)

zakłady farmaceutyczne polpharma s.a. - furozemidas - injekcinis tirpalas - 20 mg/2 ml - furosemide

Liên Minh Châu Âu - Tiếng Lít-va - EMA (European Medicines Agency)

pharmaand gmbh - rucaparib camsylate - kiaušidžių navikai - antinavikiniai vaistai - rubraca is indicated as monotherapy for the maintenance treatment of adult patients with advanced (figo stages iii and iv) high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. rubraca yra nurodyta kaip monotherapy priežiūros gydymo suaugusių pacientų su platinos-jautrus atsinaujino aukštos kokybės epitelio, kiaušidžių, kiaušintakių, arba pirminės pilvaplėvės vėžys, kuris yra atsakas (visiškas arba dalinis) platinos pagrindu chemoterapija.

Liên Minh Châu Âu - Tiếng Lít-va - EMA (European Medicines Agency)

recordati rare diseases - osilodrostat fosfatas - cushingo sindromas - kortikosteroidų sisteminis naudoti - isturisa fluorouracilu ir folino endogeninio kušingo sindromas, suaugusiems.

Liên Minh Châu Âu - Tiếng Lít-va - EMA (European Medicines Agency)

deciphera pharmaceuticals (netherlands) b.v. - ripretinib - virškinimo trakto stromos navikai - antinavikiniai vaistai - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.

Liên Minh Châu Âu - Tiếng Lít-va - EMA (European Medicines Agency)

novartis europharm limited  - capmatinib dihydrochloride monohydrate - karcinoma, nesmulkiųjų ląstelių skausmas - antinavikiniai vaistai - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.

Liên Minh Châu Âu - Tiếng Lít-va - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - maribavir - citomegalovirusinės infekcijos - antivirusiniai vaistai sisteminiam naudojimui - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). reikėtų atsižvelgti į oficialius nurodymus, kaip tinkamai naudoti antivirusinių medžiagų.

Liên Minh Châu Âu - Tiếng Lít-va - EMA (European Medicines Agency)

mylan pharmaceuticals limited - teriflunomide - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Liên Minh Châu Âu - Tiếng Lít-va - EMA (European Medicines Agency)

accord healthcare s.l.u. - teriflunomide - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantais, pasirinktinio imunosupresantais - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Lít-va - Tiếng Lít-va - SMCA (Valstybinė vaistų kontrolės tarnyba)

stada arzneimittel ag - teriflunomidas - plėvele dengtos tabletės - 14 mg - teriflunomide

Lít-va - Tiếng Lít-va - SMCA (Valstybinė vaistų kontrolės tarnyba)

krka, d.d., novo mesto - teriflunomidas - plėvele dengtos tabletės - 14 mg - teriflunomide